Skip to content

XIENCE XPEDITION 1074250-18Recalls & reported problems

Abbott Vascular Inc. · XIENCE Xpedition Everolimus Eluting Coronary Stent System 2.50 mm x 18 mm / Rapid-Exchange · Class 3 · Implant

All models of XIENCE XPEDITION (41)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648162145), received between Jan 5, 2017 and Nov 28, 2018 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Stenosis2
  • Angina1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 28, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2013 THE 2.5X18 MM XIENCE XPEDITION STENT WAS IMPLANTED IN THE MID LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY. ON (B)(6) 2018 THE PATIENT HAD STENOSIS IN THE LAD WHICH WAS FOUND THROUGH A MYOCARDIAL PERFUSION SCAN, BUT NO ISCHEMIC SYMPTOMS WERE REPORTED. IT IS UNKNOWN IF AN ANGIOGRAM OR OTHER TREATMENT WILL BE PERFORMED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Stenosis

    MAUDE report 8111827 ↗
  • InjuryJan 5, 2017Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT ON (B)(6) 2013, A 2.5X18MM XIENCE XPEDITION STENT WAS SUCCESSFULLY IMPLANTED IN THE PROXIMAL CIRCUMFLEX (CX) CORONARY ARTERY LESION. ON (B)(6) 2016, THE PATIENT WAS HOSPITALIZED FOR CHEST PAIN. PERCUTANEOUS INTERVENTION WAS PERFORMED IN THE 90% RESTENOSED STENT. THE EVENT RESOLVED AND ON (B)(6) 2016, THE PATIENT WAS DISCHARGED FROM THE HOSPITAL. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

    Patient problems: Angina; Stenosis

    MAUDE report 6226389 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page